HC Wainwright Reiterates “Neutral” Rating for OptiNose (NASDAQ:OPTN)
OptiNose (NASDAQ:OPTN – Get Free Report)‘s stock had its “neutral” rating restated by research analysts at HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $9.00 target price on the stock. HC Wainwright’s price objective points to a potential downside of 6.25% from the company’s current […]
